文献速递糖尿病

2型糖尿病发病前后BMI及BMI变化与微血管和大血管并发症风险

BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
PubMed 文献 · Diabetologia · 2021-01-15

在EPIC-Potsdam队列1083例新发2型糖尿病患者中,评估诊断前BMI及诊断前后相对年BMI变化与长期并发症风险的关系。中位随访10.8年,诊断前BMI较高与总微血管并发症、肾病风险正相关,与微血管大血管并发症无明确关联;BMI下降超过1%与总微血管并发症和肾病风险降低相关。

要点

  • 诊断前BMI每增加5 kg/m2,总微血管并发症HR 1.21,肾病HR 1.39。
  • BMI下降超过1%与总微血管并发症HR 0.62、肾病HR 0.57相关。
  • 诊断前BMI及BMI变化与大血管并发症无明确关联。

核心结论

  • 新发2型糖尿病患者中,诊断前BMI较高与微血管并发症风险正相关。
  • 与体重稳定相比,体重下降与微血管并发症风险降低相关。
  • BMI及BMI变化与大血管疾病的关系不明确。

研究设计与样本

  • 前瞻性队列研究,来自EPIC-Potsdam队列。
  • 纳入1083例新发2型糖尿病且诊断时无癌症、心血管疾病和微血管疾病者。
  • 采用多变量校正Cox模型分析诊断前BMI及诊断前后相对年BMI变化。

主要发现

  • 中位随访10.8年,发生85例大血管事件和347例微血管事件。
  • 诊断前BMI中位数29.9 kg/m2(IQR 27.4-33.2),相对年BMI变化中位数-0.4%(IQR -2.1至0.9)。
  • 诊断前BMI每增加5 kg/m2,总微血管并发症HR 1.21(95%CI 1.07-1.36),肾病HR 1.39(95%CI 1.21-1.60),神经病变HR 1.12(95%CI 0.96-1.31);大血管并发症HR 1.05(95%CI 0.81-1.36)。
  • 与BMI稳定相比,BMI下降超过1%者总微血管并发症HR 0.62(95%CI 0.47-0.80),肾病HR 0.57(95%CI 0.40-0.81),神经病变HR 0.73(95%CI 0.52-1.03);大血管并发症HR 1.04(95%CI 0.62-1.74)。
  • BMI增加与糖尿病相关血管并发症的关联较不明显;关联在从不吸烟者中似乎更强。

临床怎么用

  • 对新发2型糖尿病患者,应关注诊断前BMI水平以评估微血管并发症风险。
  • 体重管理或可作为降低微血管并发症风险的策略之一。
  • 大血管并发症的体重相关风险管理需结合其他因素综合评估。

局限性

  • 观察性研究,不能推断因果关系。
  • 大血管事件数较少(85例),关联估计精度有限。
  • BMI变化基于诊断前后测量,可能受反向因果影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Studies suggest decreased mortality risk among people who are overweight or obese compared with individuals with normal weight in type 2 diabetes (obesity paradox). However, the relationship between body weight or weight change and microvascular vs macrovascular complications of type 2 diabetes remains unresolved. We investigated the association between BMI and BMI change with long-term risk of microvascular and macrovascular complications in type 2 diabetes in a prospective cohort study. METHODS: We studied participants with incident type 2 diabetes from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort, who were free of cancer, cardiovascular disease and microvascular disease at diagnosis (n = 1083). Pre-diagnosis BMI and relative annual change between pre- and post-diagnosis BMI were evaluated in multivariable-adjusted Cox models. RESULTS: There were 85 macrovascular (myocardial infarction and stroke) and 347 microvascular events (kidney disease, neuropathy and retinopathy) over a median follow-up of 10.8 years. Median pre-diagnosis BMI was 29.9 kg/m2 (IQR 27.4-33.2), and the median relative annual BMI change was -0.4% (IQR -2.1 to 0.9). Higher pre-diagnosis BMI was positively associated with total microvascular complications (multivariable-adjusted HR per 5 kg/m2 [95% CI]: 1.21 [1.07, 1.36], kidney disease 1.39 [1.21, 1.60] and neuropathy 1.12 [0.96, 1.31]) but not with macrovascular complications (HR 1.05 [95% CI 0.81, 1.36]). Analyses according to BMI categories corroborated these findings. Effect modification was not evident by sex, smoking status or age groups. In analyses according to BMI change categories, BMI loss of more than 1% indicated a decreased risk of total microvascular complications (HR 0.62 [95% CI 0.47, 0.80]), kidney disease (HR 0.57 [95% CI 0.40, 0.81]) and neuropathy (HR 0.73 [95% CI 0.52, 1.03]), compared with participants with a stable BMI; no clear association was observed for macrovascular complications (HR 1.04 [95% CI 0.62, 1.74]). The associations between BMI gain compared with stable BMI and diabetes-related vascular complications were less apparent. Associations were consistent across strata of sex, age, pre-diagnosis BMI or medication but appeared to be stronger among never-smokers compared with current or former smokers. CONCLUSIONS/INTERPRETATION: Among people with incident type 2 diabetes, pre-diagnosis BMI was positively associated with microvascular complications, while a reduced risk was observed with weight loss when compared with stable weight. The relationships with macrovascular disease were less clear.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Polemiti E, Baudry J, Kuxhaus O, et al. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study. Diabetologia. 2021. PMID: 33452586. doi:10.1007/s00125-020-05362-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。